Israel
Index Globenewswire
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Kamis, 07 Agustus 2025 - 00:14:16 Wib Globenewswire
Cellebrite Names David Barter Chief Financial Officer
Selasa, 08 Juli 2025 - 22:10:28 Wib Globenewswire
Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
Jumat, 27 Juni 2025 - 03:23:49 Wib Globenewswire
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
Senin, 16 Juni 2025 - 22:13:00 Wib Globenewswire
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
Rabu, 04 Juni 2025 - 05:00:00 Wib Globenewswire
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T
Senin, 02 Juni 2025 - 03:21:53 Wib Globenewswire
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
Rabu, 28 Mei 2025 - 20:54:01 Wib Globenewswire
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
Rabu, 28 Mei 2025 - 03:46:55 Wib Globenewswire
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
Kamis, 22 Mei 2025 - 04:04:00 Wib Globenewswire
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
Kamis, 22 Mei 2025 - 04:02:24 Wib Globenewswire
Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
Senin, 19 Mei 2025 - 16:00:00 Wib Globenewswire
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
Senin, 19 Mei 2025 - 16:00:00 Wib Globenewswire
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
Senin, 19 Mei 2025 - 02:26:40 Wib Globenewswire
Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
Selasa, 13 Mei 2025 - 00:57:04 Wib Globenewswire
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
Rabu, 07 Mei 2025 - 18:30:00 Wib Globenewswire
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
Selasa, 08 April 2025 - 03:50:43 WibTerpopuler
Index
1
Dandim Dumai Laksanakan Pengawasan Program Dapur Makan Bergizi
Dibaca: 126 Kali
2
3
4
Terkini
Index
-
-
-
-
Dandim Dumai Laksanakan Pengawasan Program Dapur Makan Bergizi
10 Januari 2026